Displaying 1 - 12 of 38
Metabolism, Alcohol & Toxicity

Summary and Closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Approaching MASH as a metabolic disease with the need for holistic therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts
View
General Hepatology

First line assessment of liver steatosis with ultrasound: the qualitative gold standard becomes quantitative and multiparametr...

Webcasts
View
General Hepatology

E-Scopics: “Innovations in point-of-care ultrasound for the management of NAFLD-NASH: seeing is believing” (Complete Session)

Webcasts
View
General Hepatology

Introduction

Webcasts
View
General Hepatology

2D-TE with point of care ultrasound imaging: a robust and reliable alternative for liver stiffness measurement

Webcasts
View
General Hepatology

Meet one of the inventors of transient elastography: a 20-year journey of research and innovations in liver stiffness measurem...

Webcasts
View
Displaying 1 - 12 of 38